These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23954087)

  • 1. Metastatic renal cancer: better never than late.
    Galsky MD
    Eur Urol; 2014 Jun; 65(6):1093-4. PubMed ID: 23954087
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial comment on: update on the medical treatment of metastatic renal cell carcinoma.
    Ficarra V; Novara G
    Eur Urol; 2008 Aug; 54(2):324-5. PubMed ID: 18485580
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial comment on: update on the medical treatment of metastatic renal cell carcinoma.
    Van Poppel H
    Eur Urol; 2008 Aug; 54(2):324. PubMed ID: 18485572
    [No Abstract]   [Full Text] [Related]  

  • 4. Sorafenib rechalenge in metastatic renal cell carcinoma.
    Porta C; Paglino C; Imarisio I
    BJU Int; 2012 Sep; 110(6 Pt B):E235. PubMed ID: 22332769
    [No Abstract]   [Full Text] [Related]  

  • 5. The Costly War Against Cancer Treatment: The Example of Metastatic Renal Cell Carcinoma in Portugal.
    Barata PC; Alpuim Costa D; Passos Coelho JL; Da Luz R
    Acta Med Port; 2018 Aug; 31(7-8):373-375. PubMed ID: 30189164
    [No Abstract]   [Full Text] [Related]  

  • 6. Will we be able to "cure" metastatic renal cell carcinoma like we cure testicular tumours?
    Kirkali Z
    Eur Urol; 2008 Oct; 54(4):712-4. PubMed ID: 18640767
    [No Abstract]   [Full Text] [Related]  

  • 7. Intermittent sunitinib for metastatic renal cell carcinoma.
    Venkatesan P
    Lancet Oncol; 2017 Mar; 18(3):e139. PubMed ID: 28163004
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumour flare during interruption of temsirolimus treatment for metastatic renal cell cancer.
    Paterson C; Jones RJ
    Clin Oncol (R Coll Radiol); 2009 Nov; 21(9):732-3. PubMed ID: 19665360
    [No Abstract]   [Full Text] [Related]  

  • 9. Modest effect of interferon alfa on metastatic renal-cell carcinoma.
    Amato R
    Lancet; 1999 Jan; 353(9146):6-7. PubMed ID: 10023941
    [No Abstract]   [Full Text] [Related]  

  • 10. [News on ASCO 2007. Sunitinib in the treatment of metastatic renal carcinoma and gastrointestinal stromal tumors].
    Mansueto G; Longo F
    Tumori; 2007; 93(5):Suppl 1-16. PubMed ID: 18038894
    [No Abstract]   [Full Text] [Related]  

  • 11. Dose matters: the importance of appropriate dosing: a case report on sunitinib treatment in a patient with metastatic renal cell carcinoma.
    Bojic M; Schmidinger M
    Clin Genitourin Cancer; 2012 Dec; 10(4):277-9. PubMed ID: 22658385
    [No Abstract]   [Full Text] [Related]  

  • 12. Interferon for metastatic renal cell cancer causing regression of hereditary hemorrhagic telangiectasia.
    Wheatley-Price P; Shovlin C; Chao D
    J Clin Gastroenterol; 2005 Apr; 39(4):344-5. PubMed ID: 15758631
    [No Abstract]   [Full Text] [Related]  

  • 13. Mammalian target of rapamycin inhibitors: the beginning of the end or the end of the beginning?
    Powles T; Davies R; Rini B
    Eur Urol; 2014 Aug; 66(2):282-3. PubMed ID: 24091021
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful sorafenib treatment for metastatic renal cell carcinoma in a case with chronic renal failure.
    Ruppin S; Protzel C; Klebingat KJ; Hakenberg OW
    Eur Urol; 2009 Apr; 55(4):986-8; quiz 988. PubMed ID: 19004541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New treatment of metastatic renal cancer. The Danish Society of Clinical Oncology].
    Sengeløv L; Geertsen PF;
    Ugeskr Laeger; 2007 Mar; 169(12):1117. PubMed ID: 17394828
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term response with sunitinib for metastatic renal cell carcinoma.
    Ronnen EA; Kondagunta GV; Ginsberg MS; Russo P; Motzer RJ
    Urology; 2006 Sep; 68(3):672.e19-20. PubMed ID: 16979716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete response in metastatic renal cell carcinoma after radiotherapy and everolimus: a clinical case and review of the literature.
    Detti B; Francolini G; Becherini C; Olmetto E; Giacomelli I; Scartoni D; Greto D; Baldazzi V; Simontacchi G; Meattini I; Livi L
    J Chemother; 2016 Oct; 28(5):432-4. PubMed ID: 27376403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temsirolimus for advanced renal-cell carcinoma.
    Fazio N; Dettori M; Lorizzo K
    N Engl J Med; 2007 Sep; 357(10):1050; author reply 1050-1. PubMed ID: 17804854
    [No Abstract]   [Full Text] [Related]  

  • 19. Endobronchial metastases from renal cell carcinoma: a late manifestation of the disease with an increasing incidence.
    Khattak MA; Fisher RA; Pickering LM; Gore ME; Larkin JM
    BJU Int; 2012 Nov; 110(10):1407-8. PubMed ID: 22937754
    [No Abstract]   [Full Text] [Related]  

  • 20. Novel challenges associated with novel agents: the evolving scenario in renal cell carcinoma.
    Di Lorenzo G; Buonerba C
    Future Oncol; 2016 Feb; 12(3):277-9. PubMed ID: 26768297
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.